Kisspeptins, the natural ligands of the G protein-coupled receptor KISS1R, comprise a family of related peptides derived from the proteolytic processing of a common precursor encoded by the KISS1 gene. Among those, Kisspeptin-10 (Kp-10) contains the basic residues to retain full functional activity, and exhibits higher receptor affinity and biopotency than longer forms of the peptide. Although kisspeptins were first characterized by their ability to inhibit tumor metastasis, recent studies have revealed that the KISS1/KISS1R system plays an essential role in the neuroendocrine control of the reproductive axis. In this context, development and functional analysis of analogs may help searching new agonists and antagonists, as valuable tools to manipulate the KISS1/KISS1R system and, hence, fertility. We report herein functional and structural analyses of a series of Ala-substituted rat kp-10 analogs, involving [Ca Taken together, our results indicate that positions 6 and 10 are critical for kp-10 action at kiss1r, and suggest that modifications in these positions could lead to the generation of new kisspeptin agonists and/or antagonists with altered functional and perhaps binding properties. Further, they emphasize the importance of using combined, multidisciplinary approaches, including in vivo studies, to reliably evaluate structure function properties of novel kisspeptin analogs.
characterized by their ability to inhibit tumor metastasis, recent studies have revealed that the KISS1/KISS1R system plays an essential role in the neuroendocrine control of the reproductive axis. In this context, development and functional analysis of analogs may help searching new agonists and antagonists, as valuable tools to manipulate the KISS1/KISS1R system and, hence, fertility. We report herein functional and structural analyses of a series of Ala-substituted rat kp-10 analogs, involving [Ca 2+ ] i responses in rat kiss1r-transfected CHO cells, dynamic LH responses in vivo, and NMR structural studies. In vitro assays revealed that Ala-substitutions in positions 6 or 10 of kp-10 resulted in a significant increase in EC 50 values (> 6.46x10 -6 M vs. 1.54-2.6x10 -8 M for rat and human , and a substantial decrease in the proportion of responsive cells coupled to a marked increase in the time required to reach maximal response. In vivo assays showed that Ala 6 substitution diminished, and Ala 10 substitution eliminated, LH secretory responses, whereas co-administration of each analog failed to affect the LH-releasing ability of kp-10. Molecular modeling under NMR restraints revealed that kp-10 exhibits a helicoidal structure between the Asn 4 and Tyr 10 residues, with mixed α-and 3 10 characteristics. Ala 6 substitution induced limited destabilization of the helix around the position of the substitution. Ala 10 substitution was found to totally disrupt the helical structure in the C-terminal region of the molecule.
Taken together, our results indicate that positions 6 and 10 are critical for kp-10 action at kiss1r, and suggest that modifications in these positions could lead to the generation of new kisspeptin agonists and/or antagonists with altered functional and perhaps binding properties. Further, they emphasize the importance of using combined, multidisciplinary approaches, including in vivo studies, to reliably evaluate structure function properties of novel kisspeptin analogs.
Introduction
The ligand-receptor tandem comprised by kisspeptins and kiss1r has been the focus of intense research over the last decade owing to its peculiar dual pathophysiological relevance. KISS1 gene was initially discovered in 1996 as a tumor suppressor gene, and was subsequently found to inhibit metastasis in melanoma and breast cancer cells (Lee et al., 1996; Lee and Welch, 1997) . Five years later, three different groups identified kiss1r as the receptor for the family of peptides derived by proteolytic processing of a precursor protein encoded by kiss1, the kisspeptins, and characterized the basic pharmacological, signaling and functional properties of the kisspeptin/kiss1r system Muir et al., 2001; Ohtaki et al., 2001 ).
These studies also showed that KISS1 is widely produced throughout the central nervous system and other organs, such as liver, lung, gonads and prostate (Muir et al., 2001 , Ohtaki et al., 2001 . A series of subsequent reports added convincing evidence indicating that this system was able to counteract metastasis, cell migration and proliferation in different cancer cell models, and established the presence and potential pathological relevance of kisspeptins and kiss1r in different types of cancers (Mead et al., 2007; Nash and Welch, 2006) .
On a completely different scenario, two independent groups identified in late 2003 mutations in KISS1R as the underlying cause of hypogonadotropic hypogonadism in humans (de Roux et al., 2003; Seminara et al., 2003) . This finding, coupled to the ensuing demonstration that lack of kiss1r (Funes et al., 2003; Seminara et al., 2003) and, more recently, kiss1 (d'Anglemont de Tassigny et al., 2007; Lapatto et al., 2007) gene caused an identical reproductive disruption phenotype in mouse, paved the way for the unexpected establishment of kisspeptin/kiss1r as a novel, critical component for the control of the reproductive axis (Popa et al., 2008; Roa et al., 2008) .
In fact, there is now growing evidence that hypothalamic kiss1 and kiss1r act as key integrative players in the hierarchical control of reproduction, mainly by conveying to the neurons releasing GnRH the central and peripheral signals that regulate (at least) puberty onset, ovulation, and sensing of metabolic status (Popa et al., 2008; Roa et al., 2008) .
Despite the obvious interest raised by the potential pathophysiological implications of kisspeptins and kiss1r, relatively few studies have been addressed to date at elucidating in detail the structural and molecular features of this tandem, their pharmacology and related signal transduction pathways (Castaño et al., 2008) . In particular, only a limited number of reports have analyzed the structure-activity relationships of kisspeptins and kiss1r Orsini et al., 2007; Tomita et al., 2007a; Tomita et al., 2006; Tomita et al., 2007b; Tomita et al., 2008) and none has integrated the chemical structure of this peptide family, its functional features in cell models in vitro, and its effects in vivo in a physiologically relevant target.
Proteolytic processing of the precursor encoded by the kiss1 gene predominantly generates Kisspeptin-54, also known as metastin, as well as lower amounts of shorter peptide fragments, including Kisspeptin-14, Kisspeptin-13 and Kisspeptin-10 (Mead et al., 2007; Nash and Welch, 2006; Popa et al., 2008; Roa et al., 2008) . Earlier reports showed that kisspeptins share the 10-amino acid C-terminal region (H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH 2 ), which contains the canonical Arg-Phe-NH 2 motif of the RFamide peptide family. This structure is highly conserved across species, since in rat, mouse, ornithorhyncus, sheep and cow, Kp-10 only differs by one amino acid from the sequence of human and non-human primates (a C-terminal Tyr instead of Phe) (Roa and Tena-Sempere, 2007) . Functional studies indicated that all kisspeptins are highly potent in terms of receptor activation, with shorter forms being even more active than Kisspeptin-54 Muir et al., 2001; Ohtaki et al., 2001 ). Using different cell lines expressing kiss1r, it has been established that coupling of kisspeptins to this receptor induces, as its major signaling cascade, activation of phospholipase C and polyphosphoinositide (PIP 2 ) hydrolysis,
6 followed by accumulation of inositol-(1,4,5)-triphosphate, Ca 2+ mobilization, as well as phosphorylation of ERK1/2 and p38 MAP kinases (Castaño et al., 2008) . In support of this, we have shown that, in rat hypothalamic explants, kp-10 elicits GnRH secretion through the required activation of phospholipase C, mobilization of intracellular Ca 2+ and recruitment of ERK1/2 and p38 kinases (Castellano et al., 2006) .
Studies from two different groups have analyzed the structure-activity relationships of Kp-10 (Niida et al., 2006; Orsini et al., 2007; Tomita et al., 2007a; Tomita et al., 2006; Tomita et al., 2007b; Tomita et al., 2008) . These analyses indicate that the nature and the orientation of the side-chains of the five C-terminal residues are important for receptor binding and activation whereas the N-terminal amino acids are more tolerant to substitution by L-alanine or enantiomer residues Orsini et al., 2007) . In addition, in pursuing the development and analysis of new analogs for kisspeptin, one group has generated short-chain analogs, notably pentapeptides (Tomita et al., 2007a; Tomita et al., 2006; Tomita et al., 2007b; Tomita et al., 2008) . To date, compound pFBz-Phe-Gly-Leu-Arg-Trp-NH 2 is the shortest kiss1r
ligand that exhibits the same efficacy and potency as Kp-10 (Tomita et al., 2007b; Tomita et al., 2008) . In SDS micelles, Kp-13 encompasses an α -helix from residues Asn 7 to Phe 13 (Asn 4 and Phe 10 in respectively) suggesting that the disruption of this α -helix could be responsible for the lower activity of inappropriately substituted compounds (Orsini et al., 2007) .
Although these studies have provided valuable information regarding the individual contribution of each residue to kiss1r activation, there is still a lack of coordinate information on the potential activity of these modified kisspeptin compounds in a physiologically relevant target. Accordingly, in the present work, we have applied an interdisciplinary approach to attain an integrated analysis of the structure-activity relationships of a series of rat kp-10 analogs obtained by chemical substitution of each residue by alanine. To this end, we have evaluated the potential functional activity of Ala-substituted kp-10 analogs using an in vitro assay model of kiss1r-transfected CHO-K1 cells, assessed the in vivo action of kp-10 and two analogs (selected from in vitro assays) on a well-characterized, physiologically relevant target for kisspeptins, i.e., stimulation of luteinizing hormone (LH) release in rats, and finally studied the 3-D structure by molecular modeling under NMR restraints of these three selected compounds. 
Material and methods

Chemicals
Peptide synthesis
Rat metastin (rat kisspeptin-52; TSPCPPVENPTGHQRPPCATRSRLIPAPRGSVLVQ REKDMSAYNWNSFGLRY-NH 2 ), rat kp-10 (YNWNSFGLRY-NH 2 ), human Kp-10 (YNWNSFGLRF-NH 2 ) and L-alanine analogs of rat kp-10 (see Table 1 (Chatenet et al., 2006) . Peptides were deprotected and cleaved from the resin by TFA as previously described (Chatenet et al., 2006; Leprince et al., 1998) . 
Cloning of the rat kiss1r, transfection and selection of monoclonal cell lines
Genomic DNA was extracted from rat pituitaries, using the Tripure Isolation Reagent (RocheMolecular Biochemicals, Mannheim, Germany) according to the manufacturer's protocol. The full length rat kiss1r was amplified by two PCR rounds, using a high-fidelity Taq polymerase (Ecozyme; Ecogen, Barcelona, Spain). For the first PCR round, specific primers were designed at the 5' and 3' regions of the coding sequence, respectively (sense, 5´ ATGGATATGGCG 3´; antisense, 5´ AGATACTGGTCTGG 3´), according to the known sequence of rat kiss1r (GenBank accession no. AF115516). The PCR product was subjected to a second amplification This article has not been copyedited and formatted. The final version may differ from this version. pre-stimulated LH secretion were explored in orchidectomized (ORX) rats. Groups of male rats (n = 10-12) were subjected to bilateral ORX via the scrotal route as previously described (Navarro et al., 2004 injection of the analogs.
Hormone measurements
Serum LH levels were measured in duplicate using a double-antibody radioimmunoassay method and reagents supplied by the NIH (Dr. AF Parlow, NIDDK National Hormone and Peptide Program; Torrance, CA). Rat LH-I-10 was labeled with 125 I using Iodo-Gen precoated tubes, following the instructions of the manufacturer (Pierce, Rockford, IL). Hormone concentrations were expressed using reference preparation LH-RP-3 as standard. The intra-assay coefficient of variation was <10% and the sensitivity of the assay was 3.75 pg/tube. All samples were measured in the same assay. Accuracy of hormone determinations was confirmed by assessment of rat serum samples of known hormone concentrations used as external controls.
NMR spectroscopy
Each peptide was dissolved at a concentration of 1. experiments were performed with a 80-ms MLEV-17 spin lock mixing pulse. During data acquisition, the water signal was suppressed by using the pulse-field gradient based watergate technique (Piotto et al., 1992) except for the COSY experiment where a low power presaturation was applied during the relaxation delay. TOCSY and NOESY experiments were performed in the phase-sensitive mode, using proportional phase incrementation method for quadrature detection (States-TPPI) (Marion D, 1989) .
Spectra were collected with 512 and 2048 complex data points in t 1 and t 2 dimensions.
Data were processed on Silicon Graphics Indigo 2 XL or Windows workstations, using XWINNMR or TOPSPIN softwares (Bruker, Wissembourg, France). The f1 dimension was zero-filled to 1024 real data points. Time domain data were multiplied by shifted sinebell or gaussian functions in both dimensions prior to Fourier transformation.
Proton chemical shifts were reported relative to DSS taken as an internal reference.
The sequential assignment was performed at 308 K using the standard sequential assignment strategy (Wüthrich, 1986 ).
3
J HN-Hα coupling constants were measured on 1D spectra.
Experimental NMR restraints
Distance restraints for structure calculations were derived from NOE crosspeaks in the NOESY spectrum recorded at 308 K with a mixing time of 150 ms. A
NOESY spectrum recorded at 295 K allowed to solve some ambiguities due to overlapping of the resonance signals. NOE cross-peaks were integrated into distances by volume integration using the Felix software (Accelrys, Orsay, France). The NOE volumes were calibrated from well-resolved geminal H β cross-peaks. The consistency of this calibration was verified on other geminal proton distances. A range of ±25% of the calculated distance was used to define the upper and lower bounds of the restraints This article has not been copyedited and formatted. The final version may differ from this version. ]kp-10, respectively. φ dihedral angles were obtained from 3 J HN-Hα coupling constants using the Karplus relation with the Pardi coefficients. For coupling constants with multiple solutions, the value was selected according to its consistency with secondary information provided by the NOE data.
Three-dimensional structure calculation
Three-dimensional structures were calculated in vacuo on a Silicon Graphics Indigo 2 XL station with the CNX program (Accelrys), using a random simulated annealing calculation. The target function was similar to that used by Nilges et al. and a force field adapted for NMR structure determination (parallhdg.pro and topallhdg.pro in X-PLOR) was used (Nilges et al., 1988) . A first set of structures was generated, based on the amino acid sequence and on a starting set of distance restraints, using an ab initio simulated annealing protocol. During the whole process, the distance restraint force was kept to 50 kcal•Å -2 and the NOE intensities were averaged with the "sum" option. Starting from an extended conformation, a first phase of 40 ps dynamics (timestep = 2 fs) at 1000 K was followed by 20 ps slow cooling step to 100 K (time step = 2 fs). A low weight of the van der Waals repulsive term was used at high temperature to allow a large conformation sampling. The variation of the slope of the asymptote in the NOE potential function allowed a progressive fit of the distance restraints. The structures leading to no systematic distance violation larger than 0.20 Å were submitted for further refinement. A 40-ps simulated annealing procedure from 1000 K to 100 K (timestep = 2 fs) with smoothing of the van der Waals repulsions and square-shapped NOE potential, was applied. A final minimization was carried out using the force field derived from CHARMM22 (files parallh22.pro and topallh22.pro) (Brooks BR, 1983) to yield a final set of optimized structures. Analysis of the structures made it possible to This article has not been copyedited and formatted. The final version may differ from this version. (Nilges M, 1995) . A final set of structures was then generated. The final structures were analyzed by CNX and displayed by using SYBYL (Tripos, Saint Louis, MO) and MOLSCRIPT (Kraulis PJ, 1991) .
Statistical analysis
Hormonal determinations were conducted in duplicate; data are presented as 
Results
Earlier studies have shown that the C-terminal decapeptide of human Kisspeptin (45-54; Kp-10) exhibits higher receptor affinity and evokes more potent functional responses than its extended counterparts (Ohtaki et al., 2001) . To further explore the structural requirements of this core sequence, we have carried out Alascan of rat kp-10 to identify important residues for kiss1r-agonistic activity. To this aim, This article has not been copyedited and formatted. The final version may differ from this version. 
Peptide analysis
RP-HPLC analysis of rat metastin, rat and human Kp-10 and Ala-substituted rat kp-10 revealed that the purity of all peptides was higher than 99% (Table 1) . For all peptides, the molecular weight observed by MS analysis was consistent with the theoretical value (Table 1) .
In vitro functional assay for kisspeptins and synthetic substituted analogs
Activities of the peptides were determined based on the kinetics of [Ca 2+ ] i in CHO-K1 cells stably transfected with rkiss1r, by using a multi-mode FlexStation system. As shown in Fig 1A and Table 2 , kp-10 analogs generated by Ala point substitutions of amino acid residues 1 to 5 and 7 to 9, displayed EC 50 values ranging from 1.04 x 10 -8 to 1.27 x 10 -7 M, which closely resemble those found for rat and human ] i in individual CHO-K1 cells stably expressing rkiss1r. In line with the studies on cell populations, administration of kisspeptin analogs substituted in position 1 to 5 and 7 to 9 did not result in appreciable changes in response as compared to those caused by rat kp-10 and rat metastin ( Taken together, the results obtained in vitro indicate that position 6 and 10 are critical for kiss1r activation and thus possibly for kiss1r binding.
Effects of kp-10 and Ala-substituted analogs on LH secretion in vivo
In vivo studies monitored the ability of which were strictly similar to those observed in vehicle-injected controls (Fig. 3) .
This article has not been copyedited and formatted. The final version may differ from this version. The effects of the combined administration of kp-10 and each of the above analogs were also tested in vivo. In order to underscore potential antagonistic effects of the Ala-substituted peptides, and considering the enormous potency of kp-10 in inducing LH release after i.c.v. administration (Navarro et al., 2005) , 1 nmol doses of the analogs were centrally co-administered with sub-maximal 100 pmol doses of kp-10.
As shown in Figure 4 , i.c.v. injection of 100 pmol kp-10 elicited robust LH secretory responses that peaked at 15-min and progressively decreased thereafter, in keeping with previous reports (Navarro et al., 2005) . Similar secretory profiles were observed ( Fig. 4) .
Finally, the effects of selected Ala-substituted kp-10 analogs on stimulated LH secretion were also assayed in ORX rats. Of note, ORX has been proven to induce a state of increased expression of kiss1 in the hypothalamus that seems mechanistically relevant for the elevation of circulating LH levels ]kp-10 or [Ala 10 ]kp-10, with a total of 3 injections at 60-min intervals, were implemented, and serum LH levels were monitored 15-min after each injection.
As expected, one-week ORX resulted in the elevation of basal LH levels over control values in intact male rats (10.5 ± 0.9 ng/ml in ORX vs. 0.8 ± 0.16 ng/ml). with in vivo functional testing of selected compounds. In the present work, an Ala-scan of rat kp-10 was performed to determine the essential structural requirements for kiss1r agonistic activity.
Our two-pronged in vitro approach to assess the functional features of the Alasubstituted analogs revealed that the Phe 6 and Tyr 10 residues of kp-10 are critical for its kiss1r-agonistic activity. Indeed, when examined both in whole cell populations by using a FlexStation system and at the single cell level, amino acids 6 and 10 appeared as key functional residues for kp-10. The essential role of the C-terminal residue was expected, since previous studies have shown the indispensable role of this amino acid to maintain an appropriate function not only of kisspeptin Ohtaki et al., 2001; Orsini et al., 2007) but also of other members of the RF-amide family of peptides, which includes prolactin-releasing peptide and neuropeptide FF, where the C-terminal Arg-Phe is also critical for their biological activity (Boyle et al., 2005; Mazarguil et al., 2001 ). However, the native C-terminal phenylalanine residue can be This article has not been copyedited and formatted. The final version may differ from this version. replaced by different aromatic moieties, such as tyrosine, tryptophan, substitutedphenylalanine or naphtylalanine, without significant loss of potency or efficacy of RFamide peptides (Boyle et al., 2005; Mazarguil et al., 2001; Tomita et al., 2006) .
Conversely, replacement of the C-terminal phenylalanine by saturated-side-chain residues such as cyclohexylalanine suppresses the biological activity of kp-10 (Orsini et al., 2007) . In the case of neuropeptide FF, the distance of the aromatic ring from the peptide backbone seems to be crucial for access to the binding pocket since homophenylalanine and phenylglycine moieties markedly reduce the affinity of the peptide for its cognate receptor (Mazarguil et al., 2001 ).
The present results extend and complement previous studies that have analyzed the pharmacological and functional features of Ala-substituted analogs for human Kp-10 and Kp13 Orsini et al., 2007) , by applying a similar approach to that used herein. In vitro testing of human Kp-10 showed that residues Phe 6 , Leu 8 , Arg 9 and Phe 10 are crucial to the activity of the peptide Orsini et al., 2007) . Consistent with these data, we found that Phe 6 and Tyr 10 in rat kp-10 are also critical for rkiss1r activation. Conversely, in our study H-NMR spectroscopy and restrained molecular dynamics in a DPC-water mixture, a membrane-mimetic medium. The structure of rat kp-10 encompasses a helix spanning from Asn 4 to Tyr 10 , with mixed α and 3 10 characteristics, preceded by a disordered Nterminal region. Recently, the solution structure of human Kp-13 has been determined in a SDS-water mixture, another membrane mimetic medium (Orsini et al., 2007) .
Human Kp-13 differs from rat kp-10 by an N-terminal extension (Leu-Pro-Asn) and the substitution of the C-terminal residue (Phe-NH 2 instead of Tyr-NH 2 ). Interestingly, the helical structure of human Kp-13 runs from Asn 7 to Phe 13 i.e. at the same relative position as in rat kp-10, but the type of helix in human Kp-13 had not been determined (Orsini et al., 2007) . The observation that human Kp-13 and rat kp-10 share a common helical domain, together with the fact that both peptides behave as full kiss1r agonists Muir et al., 2001; Ohtaki et al., 2001 ) strongly suggests that the helical structure plays a relevant role in kiss1r binding and/or activation.
Substitution of native Phe 6 by an Ala moiety slightly modified the helical structure of the peptide. Specifically, the helix was extended by one residue in its N- appears that the shortening of the C-terminal helix may be responsible, at least in part, for the lack of activity of the peptide, as already suggested (Orsini et al., 2007 This article has not been copyedited and formatted. The final version may differ from this version. 
